Summary

As landmark trials have shown no outcome improvement with vascular bypass or percutaneous angioplasty and stenting, aggressive medical management remains the gold standard for symptomatic intracranial artery disease [Augoustides JG. J Cardiothorac Vasc Anesth 2012]. This article presented outcomes of patients in the SAMMPRIS trial who had failed antithrombotic therapy at study enrollment.